#IPLaw, #USA | Can Congress speed biosimilars to market by limiting patent litigations? https://t.co/6BaXbbRO84 https://t.co/yEY7FnpVHy
#IPLaw, #USA | Can Congress speed biosimilars to market by limiting patent litigations? https://t.co/6BaXbbRO84 https://t.co/yEY7FnpVHy